Literature DB >> 27623209

Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey.

Adam M Brufsky1, Catherine Ormerod2, Robyn Bell Dickson3, Marc L Citron4.   

Abstract

With more patients with metastatic breast cancer (MBC) living longer, patient-centered communication and shared decision making between patient and oncologist are vital to improve care and quality of life in patients with MBC. The Make Your Dialogue Count survey explored emotional needs of patients at initial diagnosis of MBC and treatment change to increase awareness about gaps and facilitate communication between patients and oncologists. The survey was conducted (June-August 2014) online, by telephone, or on paper among US women with MBC and US-licensed medical oncologists. Patient data were unweighted. Oncologist data were weighted by geographic region and years in practice by sex to match actual proportions in the population. Statistically significant differences between groups were determined by standard t-test of column proportions and means at the 95% confidence level. Between initial diagnosis of MBC and treatment change, some patients' attitudes and feelings adapted as their disease advanced. Fewer patients reported fear of the unknown (58% versus 44%) and distress over believing something could have been done to prevent disease progression (26% versus 12%), but more patients reported hope of keeping the disease stable (46% versus 59%) and confidence in treatment options (29% versus 37%). During their treatment journey, more women with children ≤17 years old were distressed because they believed something could have been done to prevent disease progression versus women with children 18+ years old or no children. There were instances of misalignment between patient expectations and what oncologists actually discussed with patients. Our findings suggest that patients exhibit an ability to adapt during their disease. Having a shared understanding of concerns and needs of patients serves to strengthen the patient-oncologist alliance and creates a framework for oncologists to tailor disease management and coping strategies to improve quality of life for patients of all ages with MBC.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast neoplasm; patient-centered care; physician-patient relations; survey

Mesh:

Year:  2016        PMID: 27623209     DOI: 10.1111/tbj.12675

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  5 in total

1.  What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.

Authors:  Gabrielle B Rocque; Aysha Rasool; Beverly R Williams; Audrey S Wallace; Soumya J Niranjan; Karina I Halilova; Yasemin E Turkman; Stacey A Ingram; Courtney P Williams; Andres Forero-Torres; Tom Smith; Smita Bhatia; Sara J Knight
Journal:  Oncologist       Date:  2019-03-14

2.  Development and Validation of the Polish Version of Questionnaire for the Assessment of Psychosocial and Functional Effects of Metastatic Breast Cancer.

Authors:  Justyna Bochenek-Cibor; Katarzyna Zawisza; Filip Georgiew; Małgorzata M Bała
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

3.  Assessment of Psychosocial and Functional Effects of Metastatic Breast Cancer in Tarnow Region of Poland and Among the Social Media Polish Group-Results from the Survey from Patients.

Authors:  Justyna Bochenek-Cibor; Katarzyna Zawisza; Filip Georgiew; Małgorzata M Bała
Journal:  J Cancer Educ       Date:  2021-12       Impact factor: 1.771

Review 4.  Support for Metastatic Breast Cancer Patients-a Systematic Review.

Authors:  Justyna Bochenek-Cibor; Magdalena Górecka; Dawid Storman; Małgorzata M Bała
Journal:  J Cancer Educ       Date:  2020-12       Impact factor: 2.037

5.  Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.

Authors:  Ami Vyas; Tyler Mantaian; Shweta Kamat; Sobha Kurian; Stephen Kogut
Journal:  J Geriatr Oncol       Date:  2021-06-05       Impact factor: 3.929

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.